Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
[An update on the treatment options for multiple sclerosis].
Acute demyelinating encephalomyelitis in a child following malaria.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Laminar cortical damage in multiple sclerosis.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
Glial influence on the blood brain barrier.
Accuracy of Postcontrast 3D Turbo Spin Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis.
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
Clarification on neuromuscular conditions in careers article.
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »